Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01432600 · MORE INFO

Limitations, agreements, and source contact

Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide · Source last updated 2017-05-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
Phase 2 nature of design may have limited power to detect statistically significant differences in some efficacy outcomes and toxicity measures.
point Of Contact
email
rachid.baz@moffitt.org
organization
H. Lee Moffitt Cancer Center and Research Institute
phone
813-745-8212
title
Dr. Rachid Baz
Complete source fields
certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
Phase 2 nature of design may have limited power to detect statistically significant differences in some efficacy outcomes and toxicity measures.
point Of Contact
email
rachid.baz@moffitt.org
organization
H. Lee Moffitt Cancer Center and Research Institute
phone
813-745-8212
title
Dr. Rachid Baz

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice